117 related articles for article (PubMed ID: 31564571)
21. Phosphatidyl inositol-3 kinase (PIK3CA) E545K mutation confers cisplatin resistance and a migratory phenotype in cervical cancer cells.
Arjumand W; Merry CD; Wang C; Saba E; McIntyre JB; Fang S; Kornaga E; Ghatage P; Doll CM; Lees-Miller SP
Oncotarget; 2016 Dec; 7(50):82424-82439. PubMed ID: 27489350
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of SHP2 by new compounds induces differential effects on RAS/RAF/ERK and PI3K/AKT pathways in different cancer cell types.
Vazhappilly CG; Saleh E; Ramadan W; Menon V; Al-Azawi AM; Tarazi H; Abdu-Allah H; El-Shorbagi AN; El-Awady R
Invest New Drugs; 2019 Apr; 37(2):252-261. PubMed ID: 29947013
[TBL] [Abstract][Full Text] [Related]
23. Deletion of the tyrosine phosphatase Shp2 in cervical cancer cells promotes reprogramming of glutamine metabolism.
Gao X; Kang J; Li X; Chen C; Luo D
FASEB J; 2023 Apr; 37(4):e22880. PubMed ID: 36943407
[TBL] [Abstract][Full Text] [Related]
24. MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells.
Shi L; Xi J; Xu X; Peng B; Zhang B
Biomed Pharmacother; 2019 Jan; 109():902-909. PubMed ID: 30551544
[TBL] [Abstract][Full Text] [Related]
25. LGR5 promotes cancer stem cell traits and chemoresistance in cervical cancer.
Cao HZ; Liu XF; Yang WT; Chen Q; Zheng PS
Cell Death Dis; 2017 Sep; 8(9):e3039. PubMed ID: 28880275
[TBL] [Abstract][Full Text] [Related]
26. NHERF1 Enhances Cisplatin Sensitivity in Human Cervical Cancer Cells.
Tao T; Yang X; Qin Q; Shi W; Wang Q; Yang Y; He J
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28085111
[TBL] [Abstract][Full Text] [Related]
27. SHP2 is a multifunctional therapeutic target in drug resistant metastatic breast cancer.
Chen H; Libring S; Ruddraraju KV; Miao J; Solorio L; Zhang ZY; Wendt MK
Oncogene; 2020 Dec; 39(49):7166-7180. PubMed ID: 33033382
[TBL] [Abstract][Full Text] [Related]
28. An increase in galectin-3 causes cellular unresponsiveness to IFN-γ-induced signal transduction and growth inhibition in gastric cancer cells.
Tseng PC; Chen CL; Shan YS; Lin CF
Oncotarget; 2016 Mar; 7(12):15150-60. PubMed ID: 26934444
[TBL] [Abstract][Full Text] [Related]
29. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
[TBL] [Abstract][Full Text] [Related]
30. MiR-1284 enhances sensitivity of cervical cancer cells to cisplatin via downregulating HMGB1.
Chen J; Li G
Biomed Pharmacother; 2018 Nov; 107():997-1003. PubMed ID: 30257412
[TBL] [Abstract][Full Text] [Related]
31. Expression of Long Noncoding RNA Urothelial Cancer Associated 1 Promotes Cisplatin Resistance in Cervical Cancer.
Wang B; Huang Z; Gao R; Zeng Z; Yang W; Sun Y; Wei W; Wu Z; Yu L; Li Q; Zhang S; Li F; Liu G; Liu B; Leng L; Zhan W; Yu Y; Yang G; Zhou S
Cancer Biother Radiopharm; 2017 Apr; 32(3):101-110. PubMed ID: 28414550
[TBL] [Abstract][Full Text] [Related]
32. Sensitivity to Fas-mediated apoptosis in high-risk HPV-positive human cervical cancer cells: relationship with Fas, caspase-8, and Bid.
Hougardy BM; van der Zee AG; van den Heuvel FA; Timmer T; de Vries EG; de Jong S
Gynecol Oncol; 2005 May; 97(2):353-64. PubMed ID: 15863130
[TBL] [Abstract][Full Text] [Related]
33. Preclinical evaluation of a new liposomal formulation of cisplatin, lipoplatin, to treat cisplatin-resistant cervical cancer.
Casagrande N; De Paoli M; Celegato M; Borghese C; Mongiat M; Colombatti A; Aldinucci D
Gynecol Oncol; 2013 Dec; 131(3):744-52. PubMed ID: 24029417
[TBL] [Abstract][Full Text] [Related]
34. Shp2 promotes metastasis of prostate cancer by attenuating the PAR3/PAR6/aPKC polarity protein complex and enhancing epithelial-to-mesenchymal transition.
Zhang K; Zhao H; Ji Z; Zhang C; Zhou P; Wang L; Chen Q; Wang J; Zhang P; Chen Z; Zhu HH; Gao WQ
Oncogene; 2016 Mar; 35(10):1271-82. PubMed ID: 26050620
[TBL] [Abstract][Full Text] [Related]
35. Regulation of SHP2 by PTEN/AKT/GSK-3β signaling facilitates IFN-γ resistance in hyperproliferating gastric cancer.
Tseng PC; Huang WC; Chen CL; Sheu BS; Shan YS; Tsai CC; Wang CY; Chen SO; Hsieh CY; Lin CF
Immunobiology; 2012 Sep; 217(9):926-34. PubMed ID: 22325465
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-186 serves as a tumor suppressor in oral squamous cell carcinoma by negatively regulating the protein tyrosine phosphatase SHP2 expression.
Cai Z; Hao XY; Liu FX
Arch Oral Biol; 2018 May; 89():20-25. PubMed ID: 29407635
[TBL] [Abstract][Full Text] [Related]
37. Suppression of long noncoding RNA NCK1-AS1 increases chemosensitivity to cisplatin in cervical cancer.
Zhang WY; Liu YJ; He Y; Chen P
J Cell Physiol; 2019 Apr; 234(4):4302-4313. PubMed ID: 30221354
[TBL] [Abstract][Full Text] [Related]
38. SH3BP1-induced Rac-Wave2 pathway activation regulates cervical cancer cell migration, invasion, and chemoresistance to cisplatin.
Wang J; Feng Y; Chen X; Du Z; Jiang S; Ma S; Zou W
J Cell Biochem; 2018 Feb; 119(2):1733-1745. PubMed ID: 28786507
[TBL] [Abstract][Full Text] [Related]
39. Heat shock protein 70 is involved in malignant behaviors and chemosensitivities to cisplatin in cervical squamous cell carcinoma cells.
Yoshidomi K; Murakami A; Yakabe K; Sueoka K; Nawata S; Sugino N
J Obstet Gynaecol Res; 2014 May; 40(5):1188-96. PubMed ID: 24689999
[TBL] [Abstract][Full Text] [Related]
40. [Establishment of a cisplatin-resistant human cervical cancer cell line].
Chen XL; Wang H; Zhang XM; Liu HQ; Liu SL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Mar; 43(2):151-5. PubMed ID: 22650020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]